Trial
NCT03780166
A Study of the Safety and Tolerability of INCB050465 in Pemphigus Vulgaris
Phase IIWITHDRAWNOTHER/UNKNOWNConfidence: LOW
Sponsor
Incyte Corporation
Collaborators
—
Condition
Pemphigus Vulgaris
Intervention
Parsaclisib
Why stopped
The study was withdrawn due to insufficient interest in study participation due to recent approval in this rare condition.
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2019-09-13